Tatva Chintan Pharma Chem Ltd

Tatva Chintan Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Tatva Chintan Pharma Chem Ltd

₹ 1,412 -0.16%
03 Nov 4:01 p.m.
tatvachintan.com BSE: 543321 NSE: TATVA
About

Tatva Chintan Pharma Chem Limited was incorporated in 1996 and it is a manufacturer of a diverse portfolio of structure Directing Agents, Phase Transfer Catalysts, electrolyte salts for batteries, and Pharmaceutical and Agrochemical Intermediates and other Speciality chemicals[1]

Key Points

Product Portfolio
The company has a portfolio of 214 products divided into 4 categories: [1]

Website BSE NSE
  • Market Cap ₹ 3,322 Cr.
  • Current Price ₹ 1,412
  • High / Low ₹ 1,469 / 610
  • Stock P/E 187
  • Book Value ₹ 316
  • Dividend Yield 0.07 %
  • ROCE 1.20 %
  • ROE 0.78 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 22.0%

Cons

  • Stock is trading at 4.47 times its book value
  • The company has delivered a poor sales growth of 7.77% over past five years.
  • Company has a low return on equity of 4.57% over last 3 years.
  • Promoter holding has decreased over last 3 years: -7.15%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
90.09 120.61 124.51 114.36 96.67 84.21 98.27 105.46 83.49 85.90 107.86 116.86 123.52
78.91 102.70 108.24 93.02 76.43 73.21 82.67 92.85 77.91 78.83 98.90 99.54 101.30
Operating Profit 11.18 17.91 16.27 21.34 20.24 11.00 15.60 12.61 5.58 7.07 8.96 17.32 22.22
OPM % 12.41% 14.85% 13.07% 18.66% 20.94% 13.06% 15.87% 11.96% 6.68% 8.23% 8.31% 14.82% 17.99%
1.55 1.08 -2.74 1.02 0.76 1.21 4.53 1.17 0.38 0.04 0.72 1.16 1.01
Interest 1.36 2.38 3.20 2.93 3.01 0.38 0.21 0.31 0.17 0.42 0.39 0.41 0.51
Depreciation 2.31 2.38 2.53 6.01 6.78 6.58 6.23 6.67 6.81 6.92 7.26 8.97 9.05
Profit before tax 9.06 14.23 7.80 13.42 11.21 5.25 13.69 6.80 -1.02 -0.23 2.03 9.10 13.67
Tax % 21.52% 18.27% -117.31% 29.21% 30.60% 34.10% 29.73% 23.53% -34.31% -165.22% 49.26% 26.92% 27.43%
7.11 11.62 16.95 9.50 7.78 3.46 9.61 5.21 -0.66 0.14 1.03 6.65 9.92
EPS in Rs 3.21 5.24 7.65 4.29 3.33 1.48 4.11 2.23 -0.28 0.06 0.44 2.84 4.24
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
136 206 263 300 434 424 394 383 434
113 172 208 234 325 363 325 348 379
Operating Profit 23 34 55 67 109 61 69 35 56
OPM % 17% 17% 21% 22% 25% 14% 17% 9% 13%
1 1 1 5 9 2 7 2 3
Interest 3 4 4 4 5 9 7 2 2
Depreciation 3 4 5 7 8 10 26 28 32
Profit before tax 19 27 48 61 104 45 44 8 25
Tax % 35% 25% 21% 14% 8% -2% 30% 25%
12 21 38 52 96 45 30 6 18
EPS in Rs 15.30 25.56 47.03 26.02 43.25 20.52 12.97 2.44 7.58
Dividend Payout % -0% -0% -0% 19% 5% 10% 15% 41%
Compounded Sales Growth
10 Years: %
5 Years: 8%
3 Years: -4%
TTM: 17%
Compounded Profit Growth
10 Years: %
5 Years: -31%
3 Years: -61%
TTM: 1%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: -17%
1 Year: 61%
Return on Equity
10 Years: %
5 Years: 10%
3 Years: 5%
Last Year: 1%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8 8 8 20 22 22 23 23
Reserves 51 72 110 146 451 493 714 715
56 77 91 90 120 170 14 36
28 31 41 59 65 74 67 61
Total Liabilities 144 188 249 315 658 759 819 836
57 67 111 120 160 196 427 526
CWIP 10 6 5 10 51 231 77 27
Investments 1 -0 -0 -0 -0 -0 10 -0
76 115 133 185 447 332 305 283
Total Assets 144 188 249 315 658 759 819 836

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
13 7 25 20 20 28 98 25
-30 -17 -40 -21 -197 -101 -121 -65
7 17 10 -5 235 38 31 17
Net Cash Flow -10 8 -5 -6 59 -36 8 -24

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 77 73 69 110 48 73 65 79
Inventory Days 148 114 175 173 319 262 320 246
Days Payable 127 71 87 114 83 52 94 60
Cash Conversion Cycle 99 116 157 169 283 283 291 264
Working Capital Days 15 46 47 74 74 25 158 148
ROCE % 22% 28% 28% 26% 9% 7% 1%

Shareholding Pattern

Numbers in percentages

4 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
79.17% 79.17% 79.17% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02% 72.02%
3.74% 3.54% 3.19% 4.40% 4.21% 3.65% 3.37% 3.33% 3.36% 3.30% 3.26% 3.40%
11.52% 11.71% 11.07% 13.78% 13.06% 12.84% 10.64% 6.83% 6.34% 5.46% 5.11% 3.87%
5.58% 5.59% 6.56% 9.79% 10.72% 11.49% 13.97% 17.81% 18.27% 19.21% 19.60% 20.72%
No. of Shareholders 71,95870,03770,79974,62874,51973,73073,91279,62379,00978,39376,79273,331

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls